Company context

Viatris Inc.

NASDAQ:VTRS

Pharmaceuticals: Major · benchmarked against Pharmaceuticals: Major inside the XLV constituent company universe.

Active tabPeers

Current readGood

Last close17.18

1M return+1.33%

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Relative comparables

Peers

Source and lookbackPeer fundamentals and stored return summaries5102 stored daily bars; peer return rows use each peer's stored price summary where available.

Sample and caveat12 closest comparables from industry, sector, and market peer pools.Use this tab for its stated job; heavier model packets stay on their own tabs.

Peer return matrix

Cumulative returns across peer horizons

Stored daily closes, when available

NASDAQ:VTRS 1W -0.61%, 1M +1.33%, 3M +3.59%, 6M +18.27%, 1Y +62.89%, 3Y +56.23%; NYSE:PFE 1W -0.26%, 1M +3.80%, 3M -2.63%, 6M -6.11%, 1Y +0.79%, 3Y -30.89%; NASDAQ:BIIB 1W -2.24%, 1M -2.10%, 3M +5.68%, 6M +7.07%, 1Y +42.20%, 3Y -24.86%; NYSE:MRK 1W +2.16%, 1M +1.08%, 3M +14.01%, 6M +12.22%, 1Y +54.73%, 3Y +18.42%; NYSE:BMY 1W +1.44%, 1M +6.29%, 3M +5.67%, 6M +1.44%, 1Y +29.72%, 3Y -1.96%; NYSE:ABBV 1W +0.68%, 1M +0.61%, 3M +19.86%, 6M +10.27%, 1Y +20.93%, 3Y +73.60%; NASDAQ:REGN 1W -3.97%, 1M -3.90%, 3M +3.10%, 6M -15.05%, 1Y +15.26%, 3Y -21.72%; NYSE:ZTS 1W -3.23%, 1M -2.88%, 3M -6.12%, 6M -39.38%, 1Y -51.39%, 3Y -61.57%; NASDAQ:INCY 1W -0.52%, 1M -1.19%, 3M +20.15%, 6M +19.84%, 1Y +34.13%, 3Y +80.59%; NASDAQ:VRTX 1W -2.57%, 1M -9.40%, 3M +8.95%, 6M +2.68%, 1Y +19.30%, 3Y +34.71%; NYSE:JNJ 1W +2.45%, 1M -2.99%, 3M +12.72%, 6M +8.19%, 1Y +45.65%, 3Y +57.78%

Company1W1M3M

6M

1Y

3Y

NASDAQ:VTRS-0.61%+1.33%+3.59%+18.27%+62.89%+56.23%

NYSE:PFE-0.26%+3.80%-2.63%-6.11%+0.79%-30.89%

NASDAQ:BIIB-2.24%-2.10%+5.68%+7.07%+42.20%-24.86%

NYSE:MRK+2.16%+1.08%+14.01%+12.22%+54.73%+18.42%

NYSE:BMY+1.44%+6.29%+5.67%+1.44%+29.72%-1.96%

NYSE:ABBV+0.68%+0.61%+19.86%+10.27%+20.93%+73.60%

NASDAQ:REGN-3.97%-3.90%+3.10%-15.05%+15.26%-21.72%

NYSE:ZTS-3.23%-2.88%-6.12%-39.38%-51.39%-61.57%

NASDAQ:INCY-0.52%-1.19%+20.15%+19.84%+34.13%+80.59%

NASDAQ:VRTX-2.57%-9.40%+8.95%+2.68%+19.30%+34.71%

NYSE:JNJ+2.45%-2.99%+12.72%+8.19%+45.65%+57.78%

Peer scorecard analytics

Different ways to compare this peer set

11 companies including target

Return leadership

NASDAQ:VTRS+62.89% 1Y · +56.23% 3Y

NYSE:MRK+54.73% 1Y · +18.42% 3Y

NYSE:JNJ+45.65% 1Y · +57.78% 3Y

NASDAQ:BIIB+42.20% 1Y · -24.86% 3Y

Risk and quality spread

NYSE:JNJGM +75.08% · ROE n/a

NYSE:ABBVGM +70.58% · ROE n/a

NYSE:ZTSGM +70.43% · ROE +67.01%

NASDAQ:INCYGM +91.22% · ROE +30.82%

Valuation screen

NYSE:ZTSP/E 12.29 · FCF yield +6.87%

NASDAQ:REGNP/E 15.87 · FCF yield +6.02%

NASDAQ:INCYP/E 16.37 · FCF yield +6.27%

NYSE:BMYP/E 17.05 · FCF yield +9.60%

Valuation versus growth

P/E against 1Y return

NASDAQ:VTRS P/E n/a 1Y +62.89%, NYSE:PFE P/E 19.03 1Y +0.79%, NASDAQ:BIIB P/E 21.22 1Y +42.20%, NYSE:MRK P/E 35.87 1Y +54.73%, NYSE:BMY P/E 17.05 1Y +29.72%, NYSE:ABBV P/E 124.93 1Y +20.93%, NASDAQ:REGN P/E 15.87 1Y +15.26%, NYSE:ZTS P/E 12.29 1Y -51.39%, NASDAQ:INCY P/E 16.37 1Y +34.13%, NASDAQ:VRTX P/E 28.01 1Y +19.30%, NYSE:JNJ P/E 29.63 1Y +45.65%

Peer heatmap

Where this company wins and lags

12 stored peers

CompanyP/E TTMPrice / SalesFCF yieldGross marginReturn on equityDebt / Equity

NASDAQ:VTRSViatris Inc.

n/an/a1.42100th pctile+8.98%91st pctile+38.90%8th pctile-1.96%10th pctile1.0050th pctile

NYSE:PFEPfizer, Inc.

19.0350th pctile2.2686th pctile+6.70%43rd pctile+65.16%14th pctile+8.29%33rd pctile0.7267th pctile

NASDAQ:BIIBBiogen Inc.

21.2233rd pctile3.1457th pctile+8.30%71st pctile+66.29%43rd pctile+7.70%17th pctile0.3583rd pctile

NYSE:MRKMerck & Company, Inc.

35.8717th pctile4.7629th pctile+4.48%14th pctile+73.44%86th pctile+18.97%67th pctile1.0733rd pctile

NYSE:BMYBristol-Myers Squibb Company

17.0567th pctile2.5771st pctile+9.60%100th pctile+66.07%29th pctile+38.84%83rd pctile2.3117th pctile

NYSE:ABBVAbbVie Inc.

124.930th pctile7.230th pctile+4.46%0th pctile+70.58%71st pctilen/an/an/an/a

NASDAQ:REGNRegeneron Pharmaceuticals, Inc.

15.8783rd pctile4.8714th pctile+6.02%29th pctile+80.93%100th pctile+14.55%50th pctile0.09100th pctile

NYSE:ZTSZoetis Inc.

12.29100th pctile3.3543rd pctile+6.87%57th pctile+70.43%57th pctile+67.01%100th pctile2.860th pctile

Color ranks each metric in the favorable direction, so lower leverage and cheaper multiples can still score green.